This tool helps clinicians assess the risk and benefit of continuing dual antiplatelet therapy (DAPT) for patients at least 12 months post-PCI. It provides a numerical DAPT Risk Score and calculates the percentage risk for key cardiovascular events.
DAPT Risk Calculator by American College of Cardiology























